Search alternatives:
significantly reported » significantly related (Expand Search), significantly restored (Expand Search), significantly predicted (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
significantly reported » significantly related (Expand Search), significantly restored (Expand Search), significantly predicted (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
-
161
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
162
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
163
-
164
-
165
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
166
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
167
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
168
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
169
-
170
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
Column charts of WiAUC in therapy and control group at baseline and follow-up.
Published 2025Subjects: -
179
-
180